Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1215-1223
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1215
Figure 1
Figure 1 Survival analysis for patients according to GC stage. A: Cancer-specific and overall survivals using the Kaplan-Meier method are shown for cStage I (n = 54), cStage II (n = 36), and cStage III (n = 30); B: Cancer-specific survival using the Kaplan-Meier method is shown for each pathological (p)Stage (P < 0.01).
Figure 2
Figure 2 Survival analysis on cStage II and III patients who underwent radical or limited lymphadenectomy. A: Cancer-specific survival using the Kaplan-Meier method is shown for all patients who underwent radical or limited lymphadenectomy; B and C: Cancer-specific survival using the Kaplan-Meier method is shown for patients with cStage II (B: n = 33) or cStage III (C: n = 25).